Use of Semaglutide acetate salt:
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
*The following content is generated by AI and is for reference only.
Overview
Semaglutide is a GLP-1 receptor agonist synthesized via solid-phase peptide synthesis. Its molecular formula is C31H48N6O5 with CAS No. 910463-68-2.
Application
- Pharmaceutical Manufacturing: Production of injectable formulations for Type 2 Diabetes management.
- Obesity Treatment: Development of weight loss therapies under strict regulatory frameworks.
- Research & Development: Use in clinical trials for cardiovascular outcome studies.
Precautions
Strictly contraindicated for patients with personal or family history of medullary thyroid carcinoma. Store at controlled room temperature (20°C–25°C) and protect from light to maintain stability.